Spardorf, Germany

Gerold Schuler

This inventor holds 18 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 6 EPO patents, primarily in Dendritic Cell Research. Top assignees: Argos Therapeutics, Inc., The Rockefeller University, Friedrich-Alexander-Universitat Erlangen-Nürnberg. Active years: 1998-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gerold Schuler. Retrieved from https://idiyas.com/inventor/gerold-schuler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18 

% Patents Active = 72.2


 

Average Co-Inventor Count = 2.8

ph-index = 6

Forward Citations = 273(Granted Patents)


Location History:

  • 91080 Spardorf, DE (2009)
  • Innsbruck, AT (1998 - 2011)
  • Spardorf, DE (2001 - 2022)

Company Filing History:


Years Active: 1998-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Dendritic Cells
NF-kB Signaling
Immunogens
Protease Activity
Cryoconservation
T Cells
Electroporation
Disease Detection
Cell Proliferation
Extracellular Vesicles
Regulatory T Cells
Antigen-Loaded Cells
18 patents (USPTO):Explore Patents

Title: Gerold Schuler: A Pioneer in Innovation

Introduction:

Gerold Schuler, a visionary inventor hailing from Spardorf, Germany, is at the forefront of technological advancements with a remarkable portfolio of 17 patents. His unwavering passion for innovation and dedication to excellence continue to inspire budding inventors worldwide.

Latest Patents:

Among Gerold Schuler's latest patents is the groundbreaking invention involving NF-KB signaling pathway-manipulated dendritic cells. This innovation focuses on manipulating the NF-KB signaling pathway of dendritic cells through RNA transfection, revolutionizing their manufacture and applications in the field. Another notable patent is the method for in vitro detection and monitoring of diseases by measuring disease-associated protease activity in extracellular vesicles. This cutting-edge technique offers a new approach to detecting and monitoring diseases based on enzymatic activity, paving the way for advancements in infectious, inflammatory, and malignant diseases.

Career Highlights:

Throughout his illustrious career, Gerold Schuler has made significant contributions to companies such as Argos Therapeutics, Inc. and The Rockefeller University. His innovative mindset and problem-solving skills have led to groundbreaking advancements in the medical and biotechnological sectors, shaping the future of healthcare and technology.

Collaborations:

Gerold Schuler has had the privilege of collaborating with esteemed professionals in the industry, including Ralph M Steinman and Kayo Inaba. These collaborations have fostered a culture of innovation and knowledge-sharing, further solidifying his reputation as a leader in the field of inventing.

Conclusion:

Gerold Schuler's impact on the world of innovation is undeniable, as his relentless pursuit of excellence continues to shape the future of technology. His pioneering spirit and dedication to pushing the boundaries of what is possible serve as a beacon of inspiration for the next generation of inventors, ensuring that his legacy will endure for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…